Evaluation of the Osteoinductivity of Atorvastatin Combined With β-TCP
1 other identifier
interventional
10
1 country
1
Brief Summary
This case series study aims to evaluate the local effects of Atorvastatin (which belongs to the family of lipid-lowering drugs, known as statins) combined with β-TCP (which is a synthetic osteoconductive bone graft), on the volume of the residual bone defects and on hastening the bone regeneration after radicular jaw cyst enucleation using CBCT-based volumetric analysis to calculate the shrinkage rate of these defects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedAugust 13, 2024
August 1, 2024
1 year
April 22, 2024
August 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Rate of shrinkage of the residual bone defect
the shrinkage of the residual bone defects after bone grafting, measured from the following formula: pre-operative cyst volume - 3/6 months post-operative defect volume/pre-operative cyst volume x 100%. it will be measured radiographically using CBCT through manual segmentation
3 moths post-operatively and 6 months post-operatively
Secondary Outcomes (1)
Incidence of Inflammation at the grafted site
1 week post-operatively, 3 months post-operatively and 6 months post-operatively
Study Arms (1)
bone grafting using atorvastatin combined with beta-TCP
EXPERIMENTALthe 10 volunteers will undergo cyst enucleation followed by filling the residual bone defects with atorvastatin combined with beta-TCP in the ratio of 0.1 mg: 14 mg.
Interventions
cyst enucleation followed by bone grafting the residual bone defects using Atorvastatin combined with β-TCP.
Eligibility Criteria
You may qualify if:
- Male and female patients
- Patients 18 to 40 years old
- Radicular cyst with a maximum diameter from 1.5 to 4.0 cm;
- Focal teeth were preserved with root canal treatment;
- No previous surgical treatment of the cyst site;
- No evidence of acute inflammation;
- In good physical status and oral health;
- Regular attendance at control visits
You may not qualify if:
- Patients \< 17 years old
- Radicular cyst with a maximum diameter \< 1.5 cm.
- Pregnancy or lactation
- Aggregate systemic pathologies such as diabetes, thyroid disorders, and bone metabolism diseases, among others;
- Patients taking calcium, bisphosphonates, glucocorticoids, or other drugs that can interfere with the metabolism of bone;
- Patients with uncontrolled periodontal conditions, endodontic conditions, and other oral disorders;
- Heavy smokers (10 cigarettes/day or more)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Cairo, Egypt
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Salah Yassin
department of oral and maxillofacial surgery, cairo university
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- post-graduate master student
Study Record Dates
First Submitted
April 22, 2024
First Posted
April 25, 2024
Study Start
December 1, 2024
Primary Completion
December 1, 2025
Study Completion
March 1, 2026
Last Updated
August 13, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share